SeaStar Medical Holding Corp (ICU) - Dilution Analysis

S-1/A filing: This prospectus relates to the resale, from time to time, of up to 2,000,000 shares of our Common Stock by Lincoln Park Capital Fund, LLC.

8-K filing: Stock split 1-for-10 | Outstanding: 34,096,420 → 3

10-Q filing | 34.1M shares outstanding

8-K filing: SeaStar Medical Holdings Corporation sold 4,960,544 shares of common stock in a registered direct offering and issued warrants to purchase up to 4,960,544 shares of common stock in a concurrent private placement, with expected net proceeds of approximately $3.9 million to be used for general corporate purposes.

8-K filing: SeaStar Medical Holdings Corporation sold 4,841,232 shares of common stock and pre-funded warrants to purchase up to 401,232 shares in a registered direct offering and warrants to purchase up to 5,242,464 shares in a concurrent private placement, with net proceeds expected to be approximately $3.6 million, to be used for general corporate purposes.

8-K filing: SeaStar Medical Holding Corporation closed a public offering of common stock, pre-funded warrants, and warrants on June 23, 2025, raising approximately $3.39 million in net proceeds for general corporate purposes. ($0.0M proceeds)

S-1/A filing: SeaStar Medical Holding Corporation is offering up to $5,000,000 shares of Common Stock and accompanying Series A & B Warrants (or Pre-Funded Warrants to purchase shares of Common Stock and accompanying Series A & B Warrants, at the election of the purchaser) at a combined price of $0.9709 per share/warrant, as well as Placement Agent Warrants to purchase up to shares of Common Stock at an exercise price of $1.2136, to raise capital for working capital purposes.

S-1 filing: SeaStar Medical Holding Corporation is offering up to 4,237,288 shares of common stock, together with warrants, and up to 4,237,288 pre-funded warrants, along with placement agent warrants to purchase up to 296,610 shares of common stock.

S-1 filing: This S-1 filing relates to the resale of common stock by Lincoln Park Capital Fund, LLC, with the company potentially receiving up to $15.0 million in gross proceeds.

10-Q filing | 10.6M shares outstanding

8-K filing: SeaStar Medical Holding Corporation entered into a purchase agreement with Lincoln Park Capital Fund, LLC, for the sale of up to $15.0 million in shares of common stock and issued 236,406 shares to Lincoln Park in consideration for its commitment.

S-3 filing: This prospectus relates to the offer and resale of up to 3,529,412 shares of common stock by a single institutional investor, underlying common stock purchase warrants with an exercise price of $1.70 per share.

10-K filing | 8.7M shares outstanding

8-K filing: SeaStar Medical Holdings Corporation entered into a Securities Purchase Agreement to issue 713,000 shares of common stock, pre-funded warrants for 2,816,412 shares, and common warrants for 3,529,412 shares, with gross proceeds of approximately $6.0 million. ($18.0M proceeds)

10-Q filing | 4.1M shares outstanding

S-3/A filing: This S-3/A filing relates to the offer and resale of up to 650,447 shares of common stock by a selling securityholder, issuable upon exercise of warrants.

S-3/A filing: This prospectus relates to the offer and resale of up to 1,014,219 shares of common stock by the holders of certain outstanding common stock purchase warrants and placement agent warrants.

10-Q filing | 4.2M shares outstanding

S-3 filing: This prospectus relates to the offer and resale of up to 1,014,219 shares of common stock by the Selling Securityholders upon exercise of warrants.

8-K filing: SeaStar Medical Holding Corporation completed a registered direct offering and concurrent private placement on July 11, 2024, issuing 947,868 shares of common stock and common stock purchase warrants to purchase up to 947,868 shares, with gross proceeds of approximately $10.0 million. ($10.0M proceeds)

S-3 filing: This S-3 filing relates to the offer and resale of up to 650,447 shares of common stock by a selling securityholder, underlying warrants with an exercise price of $20.75 per share.

8-K filing: SeaStar Medical Holding Corporation entered into a warrant redemption agreement with an institutional investor to redeem 126,330 warrants for an aggregate redemption price of $449,734.80. ($0.45M proceeds)

8-K filing: SeaStar Medical Holding Corporation redeemed $0.7 million of convertible notes and converted approximately $0.6 million in unpaid principal and $0.7 million in unpaid interest and make-whole amounts into 92,858 shares of common stock, eliminating all Investor D Notes outstanding. Investor D retains warrants to purchase 126,323 shares.

10-Q filing | 75.4M shares outstanding

10-K filing | 75.4M shares outstanding

S-3/A filing: This is an S-3/A filing for a shelf offering of common stock, consisting of up to 5,497,979 Convertible Shares and up to 2,748,992 Exercisable Shares, by selling securityholders.

8-K filing: SeaStar Medical Holdings Corporation entered into a Securities Purchase Agreement to issue 6,304,545 shares of common stock and pre-funded warrants to purchase 4,536,216 shares in a registered direct offering, and series A and B warrants to purchase 16,261,142 shares in a concurrent private placement, expecting to receive gross proceeds of approximately $9.0 million. ($9.0M proceeds)

S-3 filing: This is an S-3 filing related to the offering of up to 8,246,971 shares of common stock by selling securityholders, consisting of convertible and exercisable shares, with the company potentially receiving proceeds from warrant exercises for working capital and general corporate purposes.

8-K filing: SeaStar Medical Holding Corporation completed an Additional Closing by issuing a convertible note with an initial conversion price of $0.56 per share in a principal amount of $1,086,956.52, convertible into shares of common stock, and warrants to purchase up to 527,708 shares of Common Stock with an exercise price of $0.56 per share and an additional warrant to purchase up to 527,708 shares of Common Stock with an exercise price of $0.56 per share.

S-3/A filing: This is an S-3/A filing registering for resale up to 18,183,659 shares of common stock by a selling securityholder, consisting of convertible shares and exercisable shares.

S-3 filing: This is an S-3 filing for a shelf registration of common and preferred stock, with the proceeds intended for working capital and general corporate purposes.

S-3/A filing: This is an S-3/A filing by SeaStar Medical Holding Corporation relating to the offering of shares of its Common Stock.

8-K filing: SeaStar Medical Holding Corporation completed the fourth Additional Closing by issuing a Note with an initial conversion price equal to the lowest of (i) $0.37, (ii) the closing sale price of Common Stock on the trading day immediately preceding the date of conversion of the Note, and (iii) the average closing sale price of the Common Stock for the five (5) consecutive trading days immediately preceding the conversion date of the Note, in a principal amount of $543,478.26, and a Warrant to purchase up to 738,791 shares of Common Stock with an exercise price of $0.20 per share.

10-Q filing | 37.0M shares outstanding

RW filing: This is an RW filing indicating the withdrawal of a registration statement on Form S-1 (File No. 333-274413) by SeaStar Medical Holding Corporation due to prevailing market conditions. No securities were sold in connection with the contemplated offering.

8-K filing: SeaStar Medical Holding Corporation closed the second tranche of additional funding on August 30, 2023, by issuing a Note with an initial conversion price and a Warrant to purchase up to 738,791 shares of Common Stock.

10-Q filing | 18.6M shares outstanding

8-K filing: SeaStar Medical Holding Corporation issued a Note convertible into common stock and a warrant to purchase common stock to an institutional investor on August 7, 2023.

S-1 filing: An S-1 filing was submitted on 2023-07-20, regarding an offering of common stock.

8-K filing: SeaStar Medical Holding Corporation entered into a Share Issuance and Settlement Agreement with Vellar Opportunity Fund SPV LLC - Series 4, issuing 1,000,000 shares of common stock to Vellar in lieu of certain maturity consideration under a Prepaid Forward Purchase Agreement.

10-Q filing | 13.0M shares outstanding

POS AM filing: This is a POS AM filing for a potential offering of common stock.

POS AM filing: This prospectus relates to the offer and resale of up to 14,228,567 shares of common stock by the selling stockholder, which are issuable pursuant to the conversion of senior unsecured convertible promissory notes and warrants.

POS AM filing: This is a POS AM filing related to an offering of common stock. The document emphasizes that investors should rely only on the information provided in the prospectus and not assume its accuracy as of any date other than the prospectus date.

S-1/A filing: This is an S-1/A filing for a common stock offering. The filing does not authorize anyone to provide different information and does not assume the information is accurate as of any date other than the prospectus date. The offering is not permitted in any state where it is not allowed, and persons outside the United States must observe any restrictions relating to the offering.

POS AM filing: This is a POS AM filing for an offering of common stock, but specific details such as price, amount, or shares are not provided.

S-1 filing: This S-1 filing relates to the offer and resale of up to 14,228,567 shares of common stock by the selling stockholder, representing shares issuable pursuant to convertible notes and warrants.

POS AM filing: This is a post-effective amendment to a Form S-1 registration statement for SeaStar Medical Holding Corporation, filed under the Securities Act of 1933. The registration statement covers a potential offering of securities on a delayed or continuous basis pursuant to Rule 415.

POS AM filing: This is a post-effective amendment to a Form S-1 registration statement for SeaStar Medical Holding Corporation, filed under the Securities Act of 1933, indicating a shelf offering.

10-K filing | 13.3M shares outstanding

POS AM filing: This is a POS AM filing related to an offering of common stock.

POS AM filing: This is a POS AM filing related to a potential offering of common stock. The prospectus indicates that the company is not making an offer of these securities in any state where the offer is not permitted and that investors outside of the United States must inform themselves of any restrictions relating to the offering.

S-1 filing: This is an S-1 filing for a potential offering of common stock. The filing indicates that the company has not authorized anyone to provide different information and is not making an offer in any state where it is not permitted.

S-1/A filing: The filing registers the issuance of common stock upon exercise of warrants and the resale of common stock and warrants by selling securityholders.

S-1/A filing: This S-1/A filing registers the issuance of common stock upon exercise of warrants and the resale of common stock and warrants by selling securityholders.

S-1 filing: This S-1 filing includes the registration of 9,829,000 shares of common stock and 6,438,000 warrants to purchase common stock, offered by both the company and selling securityholders.

10-Q filing | 12.7M shares outstanding

8-K filing: LMF, SeaStar Medical and HB Strategies LLC entered into a Prepaid Forward Agreement for an equity prepaid forward transaction where Seller may purchase or reverse redemption rights as to a maximum of 700,000 shares of Class A common stock of LMF.

8-K filing: LMF Acquisition Opportunities, Inc. entered into a Prepaid Forward Agreement with Vellar Opportunity Fund SPV LLC - Series 4, allowing Seller to purchase up to 1,500,000 shares of Class A common stock of LMF (or SeaStar Medical Holdings after the merger) from holders other than LMF or its affiliates.

10-Q filing | 10.5M shares outstanding

10-Q filing | 10.5M shares outstanding

8-K filing: LMF Acquisition Opportunities, Inc. entered into a Merger Agreement with SeaStar Medical, Inc. where Merger Sub will merge with SeaStar Medical, with SeaStar Medical surviving as a wholly owned subsidiary of LMAO. ($85.0M proceeds)

10-K filing | 13.0M shares outstanding

10-Q filing | 10.5M shares outstanding

10-Q filing | 10.5M shares outstanding

10-Q filing | 9.7M shares outstanding

8-K filing: LMF Acquisition Opportunities, Inc. completed its initial public offering (IPO) on January 28, 2021, selling 10,350,000 units at $10.00 per unit, and also completed a private sale of 5,738,000 warrants to the Sponsor at $1.00 per warrant, and issued 103,500 shares of Class A Common Stock to the Underwriter as compensation. ($109.24M proceeds)

S-1/A filing: LMF Acquisition Opportunities, Inc. is offering 7,500,000 units at $10.00 per unit, each unit consisting of one share of Class A common stock and one redeemable warrant, in an initial public offering.

S-1 filing: Initial public offering of units, each consisting of one share of Class A common stock and one redeemable warrant, with an over-allotment option for additional units. The company intends to focus on transactions within the financial services industry.